The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 22, 2019

Filed:

Jun. 26, 2015
Applicants:

H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL (US);

University of South Florida, Tampa, FL (US);

Inventors:

Mark McLaughlin, Tampa, FL (US);

David L. Morse, Tampa, FL (US);

Shari Pilon-Thomas, Tampa, FL (US);

Scott Antonia, Land O'Lakes, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/08 (2019.01); A61K 49/00 (2006.01); A61K 38/19 (2006.01); A61K 38/20 (2006.01); A61K 38/17 (2006.01); A61K 47/64 (2017.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/08 (2013.01); A61K 38/179 (2013.01); A61K 38/195 (2013.01); A61K 38/208 (2013.01); A61K 47/64 (2017.08); A61K 47/646 (2017.08); A61K 49/0032 (2013.01); A61K 49/0056 (2013.01); A61K 38/00 (2013.01); A61K 2039/60 (2013.01); C07K 2319/00 (2013.01);
Abstract

The current invention pertains to a molecular conjugate comprising an antagonist of a cell surface receptor specific to a target cell and an immune effector, such as a T cell modulator, conjugated to the antagonist. The target cell can be a cell responsible for development of a disease in a subject, for example, a cancer cell. In certain embodiments, the immune effector is an immune effector protein or an immune effector fragment thereof. The current invention also pertains to a method of treating a disease in a subject, the method comprising administering to the subject a pharmaceutically effective amount of the molecular conjugates of the current invention to the subject. The methods of the current invention can be used to treat cancer, such as breast cancer, ovarian cancer, prostate cancer, lung cancer, pancreatic cancer, or melanoma.


Find Patent Forward Citations

Loading…